Opioid Use After Laparoscopic Salpingectomy
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorJohns Hopkins University
About this trial
The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids.
The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, and expectation with non-opioid methods can effectively eliminate the need for opioid prescriptions after laparoscopic salpingectomy.
Eligibility criteria
Qualifiers
Individuals with a fallopian tube (unilateral and/or bilateral)
Age 18 years old and above
Undergoing minimally invasive (laparoscopic or robotic) unilateral or bilateral salpingectomy or other tubal sterilization procedure as the primary procedure
Benign indications for salpingectomy/tubal sterilization
Disqualifiers
Chronic pain syndromes patients including fibromyalgia
Patients currently on long-term (i.e. for more than three months) opioid use
Conversion to laparotomy
Allergy or other contraindication to the prescribed medications such as acetaminophen or oxycodone
Trial design
Treatments tested in this trial
- Acetaminophen
- Ibuprofen
- Oxycodone
Treatment groups
38 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov